Anti-malarial drugs are a specialized class of anti-infectives used to prevent and treat malaria, a life-threatening disease caused by Plasmodium parasites transmitted through the bites of infected female Anopheles mosquitoes. In 2026, the global focus has shifted toward combating drug-resistant strains, particularly in Africa and Southeast Asia, making India’s role as the “global pharmacy” more critical than ever.
1. Major Classifications of Anti-Malarials
Anti-malarials are classified based on the stage of the parasite’s life cycle they target and their chemical structure:
| Category | Role in Therapy | Common Examples |
| Artemisinin-Based Combination Therapies (ACTs) | Gold Standard for uncomplicated malaria; prevents resistance. | Artemether + Lumefantrine, Artesunate + Amodiaquine. |
| Quinolines | Used for both treatment and prophylaxis (prevention). | Chloroquine, Quinine, Mefloquine. |
| Antifolates | Inhibits the parasite’s DNA synthesis. | Sulfadoxine + Pyrimethamine (SP). |
| 8-Aminoquinolines | Targets the dormant liver stage to prevent relapse. | Primaquine, Tafenoquine. |
| New Chemical Entities (2026) | Next-gen molecules designed to overcome multi-drug resistance. | Cipargamin, Ganaplacide. |
2. Significance of Anti-Malarial Manufacturing in India (2026)
As of 2026, India remains the world’s largest producer of anti-malarials, accounting for over $2.5 Billion in exports annually.
WHO Prequalification Hub: India hosts the largest number of WHO-prequalified anti-malarial manufacturing units. This is essential for participating in global tenders by organizations like The Global Fund and UNICEF.
ACT Dominance: Indian manufacturers have mastered the extraction and synthesis of Artemisinin derivatives, ensuring a stable and affordable supply of ACTs, which are the frontline defense against the deadliest malaria parasite, P. falciparum.
Pediatric-Friendly Formulations: Recognizing that children are most vulnerable, Indian firms specialize in Flavored Oral Suspensions and Dispersible Tablets that make treatment compliance easier in pediatric care.
Sterile Injectable Capacity: For severe malaria, Indian facilities produce high-quality Artesunate Injections in sterile, WHO-GMP-compliant blocks, providing critical care solutions to hospitals worldwide.
3. Why Healthy Inc. is Your Strategic Sourcing Partner
Navigating the supply of life-saving anti-malarials requires technical expertise and a reliable network. Healthy Inc. acts as your professional gateway:
Strategic Sourcing Hub: We are associated with multiple state-of-the-art manufacturing units specializing in anti-infectives. Whether you need ACT tablets, Primaquine for relapse prevention, or Artesunate Vials, we match you with the right facility.
Pharmacist-Led Technical Vetting: We provide “straight answers” on drug stability and dissolution. Our team vets every batch for 99% therapeutic efficacy, which is vital in preventing the spread of resistant malaria strains.
Regulatory & Dossier Mastery: We simplify international trade by providing full CTD/ACTD dossiers, stability data for Zone IV (Tropical climates), and all necessary export certifications required for government tenders.
Cold-Chain & Logistics: We ensure that sensitive formulations are handled with care, maintaining the integrity of the medication from the Indian manufacturing floor to your destination.
Showing all 26 results
Amodiaquine Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Yellow) or Film Coated Tablets. The strength is typically expressed in terms of the Amodiaquine Base.
Active Ingredient Strength (Base Equivalent) Salt Content (Approx) Role Amodiaquine HCl USP/BP 67.5 mg ~ 90 mg Pediatric (ACT Component) Amodiaquine HCl USP/BP 153 mg / 150 mg ~ 200 mg Adolescent / Co-blistered Amodiaquine HCl USP/BP 200 mg ~ 260 mg Standard Adult Dose Excipients Q.S. Microcrystalline Cellulose / Magnesium Stearate Direct Compression Arteether Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Oily Solution in Amber Glass Ampoules. The oily base (refined Arachis Oil or Ethyl Oleate) ensures depot formation in the muscle.
Active Ingredient Strength (Standard) Therapeutic Role α-β Arteether 150 mg / 2 ml Adult Dose (Standard) α-β Arteether 75 mg / 1 ml Pediatric Dose Vehicle Q.S. Refined Arachis Oil / Ethyl Oleate Oily Base (Sustained Release) *Pack Sizes: Tray of 3 Ampoules (Full Course) or Box of 10 Ampoules.
Artemether & Lumefantrine Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (Yellow) or Dispersible Tablets (Sweetened for Pediatrics). The standard regimen is a fixed ratio of 1:6.
Strength Variant Artemether Content Lumefantrine Content Target Patient Standard / Pediatric 20 mg 120 mg Infants & Children (5kg–35kg) Double Strength (DS) 40 mg 240 mg Adolescents / Simplified Dosing Adult Forte (80/480) 80 mg 480 mg Adults (>35kg) – High Compliance Artemether 40mg Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Oily Solution in Amber Glass Ampoules. The oily base ensures a depot effect for sustained release.
Active Ingredient Strength (Standard) Therapeutic Role Artemether IP/Ph.Int 40 mg / 1 ml Pediatric / Low Body Weight Dose Artemether IP/Ph.Int 80 mg / 1 ml Adult Standard Dose Vehicle Q.S. Refined Arachis Oil / Ethyl Oleate Oily Base (Depot) *Pack Sizes: Tray of 6 Ampoules or 10 Ampoules (Standard Course).
Artemether-80 Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Oily Solution in Amber Glass Ampoules. The 80mg strength is specifically formulated to minimize the injection volume for adult patients while delivering a potent therapeutic dose.
Active Ingredient Strength (Adult Dose) Therapeutic Role Artemether IP/Ph.Int 80 mg Potent Antimalarial Vehicle Q.S. to 1 ml Refined Arachis Oil / Ethyl Oleate *Pack Sizes: Tray of 6 Ampoules or 10 Ampoules (Standard Adult Course).
Artesunate & Amodiaquine Tablets
FreeProduct Composition & Available Strengths
We supply this product in both modern co-formulated Fixed-Dose Combination (FDC) single tablets and customized co-blistered kits, accurately titrated for adult and pediatric compliance.
Formulation Format Active Ingredient Mix (per Dose) Target Patient Segment Primary Clinical Function Infant / Pediatric FDC 25 mg Artesunate + 67.5 mg Amodiaquine Infants (2 months to less than 1 year) Early Intervention: Specially sized for pediatric dispersal. Toddler / Child FDC 50 mg Artesunate + 135 mg Amodiaquine Children (1 year to less than 6 years) Growth Tier: Optimized for easy pediatric administration. Youth / Adolescent FDC 100 mg Artesunate + 270 mg Amodiaquine Adolescents (6 years to less than 14 years) Intermediate Tier: Ensures accurate dosing for older children. Adult Potency FDC 100 mg + 270 mg (2 Tablets/Day) or 200 mg + 540 mg Adults & Children over 14 years Full Strength: Complete 3-day treatment matrix. Artesunate & Mefloquine Tablet
FreeProduct Composition & Compliance Configurations
We supply this combination in both co-formulated Fixed-Dose Combination (FDC) single tablets and customized, color-coded co-blistered kits calibrated for adult and pediatric treatment regimens.
Product Packaging Format Active Ingredient Mix (per Dose) Target Patient Cohort Primary Clinical Function Pediatric Compliance FDC 25 mg Artesunate + 55 mg Mefloquine Infants & Children (6 months to less than 7 years) Micro-Dose Accuracy: Optimized for easy pediatric disintegration and ingestion. Adolescent Strength FDC 100 mg Artesunate + 220 mg Mefloquine Youth & Teenagers (7 years to less than 14 years) Intermediate Titration: Ensures balanced dosing without neuro-toxicity risks. Adult Potency FDC / Kit 100 mg + 220 mg (2 Tablets/Day for 3 days) or 200 mg + 440 mg Adults & Children over 14 years Full Strength Treatment: Maximizes biomass eradication in multi-drug resistant zones. Artesunate & Sulphadoxine-Pyrimethamine Tablets
FreeProduct Composition & Kit Configuration
We supply this product in standardized, age-titrated Fixed-Dose Combination (FDC) Blister Strips, commonly containing a 3-day course of Artesunate tablets alongside a single-dose treatment of Sulfadoxine-Pyrimethamine.
Component Tablet Type Active Ingredient Mix Standard Strengths (per Tablet) Primary Clinical Function Artesunate Tablet Artesunate 50 mg / 100 mg / 200 mg The Fast Cleaver: Clears parasite biomass over 3 consecutive days. Sulfadoxine-Pyrimethamine Tablet Sulfadoxine + Pyrimethamine 500 mg + 25 mg The Extended Shield: Single-dose companion to prevent recrudescence. Artesunate 120mg Injection
FreeProduct Composition & Strength
We supply this product as a Combi-Pack containing the Lyophilized Powder and special solvents required for activation.
Component Content Function Vial (Powder) Artesunate 120 mg (Sterile Lyophilized) Active Antimalarial Ampoule 1 Sodium Bicarbonate Injection (5%) – 1ml Activator / Solvent (Solubilizes the acid) Ampoule 2 Sodium Chloride Injection (0.9%) – 5ml Diluent (Adjusts volume/tonicity) *Pack Sizes: Single Combi-Pack or Tray of 5 Combi-Packs.
Artesunate 30mg Injection
FreeProduct Composition & Strength
We supply this product as a Combi-Pack containing the Lyophilized Powder and special solvents required for activation.
Component Content Function Vial (Powder) Artesunate 30 mg (Sterile Lyophilized) Active Antimalarial Ampoule 1 Sodium Bicarbonate Injection (5%) – 0.5ml Activator (Solubilizes the acid) Ampoule 2 Sodium Chloride Injection (0.9%) – 2.5ml Diluent (Adjusts volume/tonicity) *Pack Sizes: Single Combi-Pack or Tray of 5/10 Combi-Packs.
Artesunate 60mg Injection
FreeProduct Composition & Strength
We supply this product as a Combi-Pack containing the Lyophilized Powder and special solvents required for activation.
Component Content Function Vial (Powder) Artesunate 60 mg (Sterile Lyophilized) Active Antimalarial Ampoule 1 Sodium Bicarbonate Injection (5%) – 0.5ml/1ml Activator (Solubilizes the acid) Ampoule 2 Sodium Chloride Injection (0.9%) – 2.5ml/5ml Diluent (Adjusts volume/tonicity) *Pack Sizes: Single Combi-Pack or Tray of 5 Combi-Packs.
Artesunate Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. Stability is a key factor in our formulation.
Active Ingredient Strength (Standard) Role Artesunate IP/BP 50 mg Pediatric / Initial Dose Artesunate IP/BP 100 mg Adult Standard Dose Artesunate IP/BP 200 mg High Strength (Combination Protocols) Chloroquine Phosphate Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Solution in Amber Glass Vials/Ampoules.
Active Ingredient Salt Strength Base Equivalent Chloroquine Phosphate USP/BP 64.5 mg / ml Equivalent to 40 mg Chloroquine Base Total Vial Content 30 ml Multi-dose Vial 1200 mg Base Total Excipients Chlorocresol (Preservative) Water for Injection *Pack Sizes: Tray of 10 Ampoules (5ml) or Multi-dose Vials (30ml).
Chloroquine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets or Uncoated Tablets. The strength is often labeled by the salt weight or the base equivalent.
Active Ingredient Salt Strength Base Equivalent (Active) Primary Role Chloroquine Phosphate USP/BP 250 mg 150 mg Base Pediatric / Prophylaxis Chloroquine Phosphate USP/BP 500 mg 300 mg Base Standard Adult Dose Excipients Q.S. Maize Starch / Magnesium Stearate Binder / Lubricant Chloroquine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The coating is critical to mask the intensely bitter taste of the drug. Note: Dosing is often calculated based on the “Base” content.
Active Ingredient (Salt) Equivalent Base Primary Role Chloroquine Phosphate USP/BP 250 mg ~ 155 mg Base Prophylaxis / Maintenance Chloroquine Phosphate USP/BP 500 mg ~ 310 mg Base Acute Malaria Treatment Excipients Q.S. Starch / Magnesium Stearate Mefloquine Tablet
FreeProduct Composition & Configuration
We supply Mefloquine Hydrochloride in the internationally standardized strength calibrated for both adult therapeutic clearance and weekly travel prophylaxis.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Mefloquine Hydrochloride IP / BP / USP 250 mg
(Equivalent to 228 mg Mefloquine Base)
Oral Solid Uncoated Tablet (Cross-scored for exact pediatric dividing) Dual-Mode Antimalarial: High-dose 3-day treatment for active clearance, or low-dose once-weekly regimen for traveler chemoprophylaxis. Excipients Pharma Grade Microcrystalline Cellulose, Lactose, Magnesium Stearate The Disintegration Core: Engineered for uniform mechanical compression and rapid disintegration. Primaquine Tablets
FreePrimaquine Phosphate Tablets IP 2.5 mg
Each Sugar Coated Tablet contains :
Primaquine Phosphate IP
Eq. To Primaquine 2.5 mgPrimaquine Phosphate tablets IP 2.5 mg
EACH FILM COATED TABLET CONTAINS:
Primaquine phosphate IP Equivalent to primaquine 2.5 mg
Primaquine Phosphate Tablets IP 7.5 mg
Each Sugar Coated Tablet contains :
Primaquine Phosphate IP
Eq. To Primaquine 7.5 mgPrimaquine Phosphate tablets IP 7.5 mg
EACH FILM COATED TABLET CONTAINS:
Primaquine phosphate IP , Equivalent to primaquine 7.5 mg
PRIMAQUINE PHOSPHATE TABLETS IP 15 MG
Each film coated Tablet Contains:
Primaquine Phosphate IP equivalent to primaquine 15 mgExcipients q.s.
Primaquine Phosphate Tablets 2.5 mg
Each Sugar coated Tablet contains:
Primaquine Phosphate BP
Eq. To Primaquine 2.5 mg
Excipients q.sPRIMAQUINE TABLETS 7.5 MG
Each film coated tablet contains:
Primaquine Phosphate BP – eq. to primaquine BP 7.5 mg
– Redoxide of iron –
– Excipients – QSUsage: – Treat or prevent malaria
Category: – Antimalarial drugs
Therapeutic category: – Antimalarial
Pyrimethamine Tablets
FreePYRIMETHAMINE TABLEST IP 25 MG
EACH UNCOATED TABLET CONTAINS
PYRIMETHAMINE IP 25 MG
EXCIPENTSUsage: – Treat a serious parasite infection
Category: – Antimalarial drugs
Therapeutic category: – Antimalarial
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Quinine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile, Clear, Pale Yellow Aqueous Solution in glass ampoules.
Active Ingredient Concentration Total Content & Format Quinine Dihydrochloride BP 300 mg / ml 600 mg in 2 ml Glass Ampoule Excipients Water for Injection Preservative-Free Solution *Pack Sizes: Tray of 10 Ampoules or Box of 100 Ampoules.
Quinine Sulphate Tablets
FreeGlaquine
Quinine Sulphate Tablets BP 300 mg
Eac Sugarcoated tablet contains :
Quinine Sulphate BP 300 mgUsage: – treat malaria caused by mosquito bites
Category: – Antimalarial drugs
Therapeutic category: – Antimalarial
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Sulfadoxine Pyrimethamine Tablets
FreeGomaxine
Sulfadoxine and Pyrimethamine tablets USP
Each Uncoated tablet contains :
Sulfadoxine USP 500 mg
Pyrimethamine USP 25 mgSULPHADOXINE 7 PYRIMETHAMINE TABLETS IP Each uncoated tablet contains: Sulphadoxine IP 125 mg Pyrimethamine IP 6.25 mg Excipients q.s.
Usage: – treat malaria
Category: – Antimalarial drugs
Therapeutic category: – Antimalarial
